KR20050120670A - 로시글리타존 말레에이트의 다형체의 제조 방법 - Google Patents
로시글리타존 말레에이트의 다형체의 제조 방법 Download PDFInfo
- Publication number
- KR20050120670A KR20050120670A KR1020057018143A KR20057018143A KR20050120670A KR 20050120670 A KR20050120670 A KR 20050120670A KR 1020057018143 A KR1020057018143 A KR 1020057018143A KR 20057018143 A KR20057018143 A KR 20057018143A KR 20050120670 A KR20050120670 A KR 20050120670A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- rosiglitazone maleate
- solvent
- mixture
- rosiglitazone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307259.2A GB0307259D0 (en) | 2003-03-28 | 2003-03-28 | Process |
| GB0307259.2 | 2003-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050120670A true KR20050120670A (ko) | 2005-12-22 |
Family
ID=9955778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057018143A Withdrawn KR20050120670A (ko) | 2003-03-28 | 2004-03-25 | 로시글리타존 말레에이트의 다형체의 제조 방법 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070167494A1 (https=) |
| EP (1) | EP1615918A1 (https=) |
| JP (1) | JP2006521340A (https=) |
| KR (1) | KR20050120670A (https=) |
| CN (1) | CN1768057A (https=) |
| AU (2) | AU2004224068A1 (https=) |
| BR (1) | BRPI0408752A (https=) |
| CA (1) | CA2520249A1 (https=) |
| EA (1) | EA009331B1 (https=) |
| EC (1) | ECSP056038A (https=) |
| GB (1) | GB0307259D0 (https=) |
| IS (1) | IS8087A (https=) |
| MA (1) | MA27727A1 (https=) |
| MX (1) | MXPA05010413A (https=) |
| NO (1) | NO20054911L (https=) |
| OA (1) | OA13042A (https=) |
| WO (1) | WO2004085435A1 (https=) |
| ZA (1) | ZA200507100B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| WO2018140092A1 (en) | 2017-01-27 | 2018-08-02 | Obrien Christopher F | Methods for the administration of certain vmat2 inhibitors |
| ES3024958T3 (en) | 2017-09-21 | 2025-06-05 | Neurocrine Biosciences Inc | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| JP2021502959A (ja) | 2017-10-10 | 2021-02-04 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 特定のｖｍａｔ２インヒビターを投与するための方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9723295D0 (en) * | 1997-11-04 | 1998-01-07 | Smithkline Beecham Plc | Novel process |
| UA67844C2 (uk) * | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
| PL351685A1 (en) * | 1999-04-23 | 2003-06-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| DE60004658T2 (de) * | 1999-04-23 | 2004-06-24 | Smithkline Beecham Plc, Brentford | Thiazolidindionderivat und seine verwendung als antidiabetikum |
| CZ2003864A3 (cs) * | 2000-09-26 | 2004-01-14 | Dr. Reddy´S Research Foundation | Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy |
-
2003
- 2003-03-28 GB GBGB0307259.2A patent/GB0307259D0/en not_active Ceased
-
2004
- 2004-03-25 KR KR1020057018143A patent/KR20050120670A/ko not_active Withdrawn
- 2004-03-25 BR BRPI0408752-6A patent/BRPI0408752A/pt not_active IP Right Cessation
- 2004-03-25 OA OA1200500267A patent/OA13042A/en unknown
- 2004-03-25 WO PCT/GB2004/001306 patent/WO2004085435A1/en not_active Ceased
- 2004-03-25 CA CA002520249A patent/CA2520249A1/en not_active Abandoned
- 2004-03-25 US US10/551,021 patent/US20070167494A1/en not_active Abandoned
- 2004-03-25 EP EP04723254A patent/EP1615918A1/en not_active Withdrawn
- 2004-03-25 CN CNA2004800083916A patent/CN1768057A/zh active Pending
- 2004-03-25 AU AU2004224068A patent/AU2004224068A1/en not_active Abandoned
- 2004-03-25 EA EA200501527A patent/EA009331B1/ru unknown
- 2004-03-25 MX MXPA05010413A patent/MXPA05010413A/es unknown
- 2004-03-25 JP JP2006506028A patent/JP2006521340A/ja not_active Withdrawn
-
2005
- 2005-09-05 ZA ZA200507100A patent/ZA200507100B/en unknown
- 2005-09-26 EC EC2005006038A patent/ECSP056038A/es unknown
- 2005-10-11 MA MA28549A patent/MA27727A1/fr unknown
- 2005-10-24 NO NO20054911A patent/NO20054911L/no not_active Application Discontinuation
- 2005-10-24 IS IS8087A patent/IS8087A/is unknown
-
2008
- 2008-10-30 AU AU2008237610A patent/AU2008237610A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| OA13042A (en) | 2006-11-10 |
| IS8087A (is) | 2005-10-24 |
| EA200501527A1 (ru) | 2006-02-24 |
| EA009331B1 (ru) | 2007-12-28 |
| CN1768057A (zh) | 2006-05-03 |
| MXPA05010413A (es) | 2005-11-04 |
| BRPI0408752A (pt) | 2006-03-28 |
| ZA200507100B (en) | 2006-07-26 |
| NO20054911L (no) | 2005-10-24 |
| AU2008237610A1 (en) | 2008-11-27 |
| US20070167494A1 (en) | 2007-07-19 |
| JP2006521340A (ja) | 2006-09-21 |
| AU2004224068A1 (en) | 2004-10-07 |
| WO2004085435A1 (en) | 2004-10-07 |
| EP1615918A1 (en) | 2006-01-18 |
| CA2520249A1 (en) | 2004-10-07 |
| MA27727A1 (fr) | 2006-01-02 |
| ECSP056038A (es) | 2006-01-27 |
| GB0307259D0 (en) | 2003-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8722722B2 (en) | Raltegravir salts and crystalline forms thereof | |
| AU2008237610A1 (en) | Process for preparing a polymorph of rosiglitazone maleate | |
| ZA200407799B (en) | Lansoprazole polymorphs and processes for preparation thereof | |
| US20090076272A1 (en) | Polymorphs of eszopiclone malate | |
| HUP0402536A2 (hu) | Meloxicam új kristályformái és eljárás ezek előállítására és egymásba alakítására | |
| EP0844997A1 (en) | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation | |
| US5700820A (en) | Polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation | |
| US8063214B2 (en) | Polymorphic forms of tadalafil | |
| US20110015247A1 (en) | Novel crystalline form of carvedilol dihydrogen phosphate and related processes | |
| US20050143396A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| WO2011080651A2 (en) | Polymorphic forms of febuxostat | |
| EP3656768A1 (en) | Beraprost-314d crystals and methods for preparation thereof | |
| CA2464961A1 (en) | Polymorphous forms of rosiglitazone maleate | |
| EP1973893B1 (en) | Process for preparing crystalline form ii of orlistat | |
| EP2079723B1 (en) | Process for preparing anhydrous aripiprazole type i | |
| AU700976B2 (en) | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation | |
| JPH0429990A (ja) | 光学活性なシス―チアゾリジン―４―オン誘導体の製造法 | |
| EP2109613A2 (en) | Polymorphs of eszopiclone malate | |
| WO2014024210A2 (en) | Novel polymorphs of doxercalciferol | |
| WO2006010653A1 (en) | New polymorphous form of rosiglitazone maleate | |
| WO2006109318A1 (en) | Novel polymorph of 3-hydroxy-3-(3’-sulfamyl-4’-chlorophenyl)phthalimidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050927 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |